Satish Tripathi, Ph.D., M.P.H., founded Biomedical Consulting International, Inc. as a consulting firm following his extensive experience as a Reviewer at the US FDA and after holding senior level positions in global regulatory affairs at Baxter, Pharmacia,Pfizer, Jonhson & Johnson. BCI has established its headquarters in Chicago, Illinois with additional locations in New York, London, UK and Mumbai, India.

Dr. Tripathi brings tremendous experience to his role as BCI's president, having participated on both sides of the "Drug Approval Process". During his 4-year tenure at FDA, he played an important role in the review and evaluation of DMF, INDs and NDAs. In addition, during his 20+ years career in industry, he played a significant role in the approval of INDs and NDAs/BLAs covering a wide range of therapeutic areas.

Dr. Tripathi is continuing to lead BCI consistent with his vision to build an international consulting organization with a commitment to provide clients with direct access to experienced senior level consultants and to produce work products of outstanding quality with maximum flexibility (working towards 24 hours/day and 7 days/week) by coordinating and optimizing efforts of Biomedical Consulting International, Inc's global network of offices.